Acta Parasitologica

, Volume 60, Issue 1, pp 105–111 | Cite as

The in vitro antimalarial interaction of 9-hydroxycalabaxanthone and α-mangostin with mefloquine/artesunate

  • Wanna Chaijaroenkul
  • Kesara Na-BangchangEmail author


Multidrug resistance Plasmodium falciparum is the major health problem in Thailand. Discovery and development of new antimalarial drugs with novel modes of action is urgently required. The aim of the present study was to investigate the antimalarial interaction of 9-hydroxycalabaxanthone and α-mangostin with the standard antimalarial drugs mefloquine and artesunate in chloroquine sensitive (3D7) and chloroquine resistant (K1) P. falciparum clones in vitro. Median (range) IC50 (drug concentration which produces 50% parasite growth inhibition) values of the 9-hydroxycalabaxanthone, α-mangostin, artesunate and mefloquine for 3D7 vs K1 clones were 1.5 (0.9–2.1) vs 1.2 (1.1–1.6) μM, 17.9 (15.7.0–20.0) vs 9.7 (6.0–14.0) μM, 1.0 (0.4–3.0) vs 1.7 (1.0–2.5) nM, and 13.3 (11.1–13.3) vs 7.1 (6.7–12.2) nM, respectively. Analysis of isobologram and combination index (CI) of 9-hydroxycalabaxanthone with artesunate or mefloquine showed synergistic and indifference antimalarial interaction, respectively. α-mangostin-artesunate combination exhibited a slight antagonistic effect of antimalarial interaction, whereas α-mangostin and mefloquine combination showed indifference interaction in both clones. The combination of 9-hydroxycalabaxanthone with α-mangostin showed the synergistic antimalarial interaction in both clones.


Multidrug resistance Plasmodium falciparum 9-hydroxycalabaxanthone α-mangostin drug combination 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Akao Y., Nakagawa Y., Iinuma M., Nozawa Y. 2008. Anti-cancer effects of xanthones from pericarps of mangosteen. International Journal of Molecular Sciences, 9, 355–370CrossRefGoogle Scholar
  2. Bennett T.N., Paguio M., Gligorijevic B., Seudieu C., Kosar A.D., Davidson E., Roepe P.D. 2004. Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy. Antimicrobial Agents and Chemotherapy, 48, 1807–1810CrossRefGoogle Scholar
  3. Bumrungpert A., Kalpravidh R.W., Chuang C.C., Overman A., Martinez K., Kennedy A., McIntosh M. 2010. Xanthones from mangosteen inhibit inflammation in human macrophages and in human adipocytes exposed to macrophage-conditioned media. Journal of Nutrition, 140, 842–847. DOI: jn.109.120022[pii]10.3945/jn.109.120022CrossRefGoogle Scholar
  4. Carrara V.I., Zwang J., Ashley E.A., Price R.N., Stepniewska K., Barends M., Brockman A., Anderson T., McGready R., Phaiphun L., Proux S., van Vugt M., Hutagalung R., Lwin K.M., Phyo A.P., Preechapornkul P., Imwong M., Pukrittayakamee S., Singhasivanon P., White N.J., Nosten F. 2009. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PloS one, 4, e4551. DOI:10.1371/journal.pone.0004551CrossRefGoogle Scholar
  5. Chaijaroenkul W., Mubaraki M., Ward S.A., Na-Bangchang K., (2014). Metabolite footprinting of Plasmodium falciparum following exposure to Garcinia mangostana Linn. crude extract. Exp Parasitol, DOI: Scholar
  6. Chen L.G., Yang L.L., Wang C.C. 2008. Anti-inflammatory activity of mangostins from Garcinia mangostana. Food and Chemical Toxicology, 46, 688–693. DOI: S0278-6915(07)00444-9[pii]10.1016/j.fct.2007.09.096CrossRefGoogle Scholar
  7. Chin Y.W., Jung H.A., Chai H., Keller W.J., Kinghorn A.D. 2008. Xanthones with quinone reductase-inducing activity from the fruits of Garcinia mangostana (Mangosteen). Phytochemistry, 69, 754–758. DOI: S0031-9422(07)00596-1 [pii]10.1016/j.phytochem.2007.09.023CrossRefGoogle Scholar
  8. Chomnawang M.T., Surassmo S., Wongsariya K., Bunyapraphatsara N. 2009. Antibacterial activity of Thai medicinal plants against methicillin-resistant Staphylococcus aureus. Fitoterapia, 80, 102–104. DOI: S0367-326X(08)00214-1 [pii]10.1016/j.fitote.2008.10.007CrossRefGoogle Scholar
  9. Devi Sampath P., Vijayaraghavan K. 2007. Cardioprotective effect of alpha-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats. Journal of Biochemical and Molecular Toxicology, 21, 336–339. DOI: 10.1002/jbt.20199CrossRefGoogle Scholar
  10. Fivelman Q.L., Adagu I.S., Warhurst D.C. 2004. Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drugresistant strains of Plasmodium falciparum. Antimicrobial Agents and Chemotherapy, 48, 4097–4102. DOI: 48/11/4097[pii]10.1128/AAC.48.11.4097-4102.2004CrossRefGoogle Scholar
  11. Han A.R., Kim J.A., Lantvit D.D., Kardono L.B., Riswan S., Chai H., Carcache de Blanco E.J., Farnsworth N.R., Swanson S.M., Kinghorn A.D. 2009. Cytotoxic xanthone constituents of the stem bark of Garcinia mangostana (mangosteen). Journal of Natural Products, 72, 2028–2031. DOI: 10.1021/np900517hCrossRefGoogle Scholar
  12. Hay A.E., Helesbeux J.J., Duval O., Labaied M., Grellier P., Richomme P. 2004. Antimalarial xanthones from Calophyllum caledonicum and Garcinia vieillardii. Life Sciences, 75, 3077–3085. DOI: S0024-3205(04)00750-7 [pii]10.1016/j.lfs.2004.07.009CrossRefGoogle Scholar
  13. Ho C.K., Huang Y.L., Chen C.C. 2002. Garcinone E, a xanthone derivative, has potent cytotoxic effect against hepatocellular carcinoma cell lines. Planta Medica, 68, 975–979. DOI:10.1055/s-2002-35668CrossRefGoogle Scholar
  14. Jung H.A., Su B.N., Keller W.J., Mehta R.G., Kinghorn A.D. 2006. Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen). Journal of Agricultural and Food Chemistry, 54, 2077–2082. DOI: 10.1021/jf052649zCrossRefGoogle Scholar
  15. Kaomongkolgit R., Jamdee K., Chaisomboon N. 2009. Antifungal activity of alpha-mangostin against Candida albicans. Journal of Oral Science, 51, 401–406. DOI: JST.JSTAGE/josnusd/51.401 [pii]CrossRefGoogle Scholar
  16. Lannang A.M., Louh G.N., Lontsi D., Specht S., Sarite S.R., Florke U., Hussain H., Hoerauf A., Krohn K. 2008. Antimalarial compounds from the root bark of Garcinia polyantha Olv. The Journal of Antibiotics (Tokyo), 61, 518–523. DOI: ST.JSTAGE/antibiotics/61.518 [pii]10.1038/ja.2008.70CrossRefGoogle Scholar
  17. Likhitwitayawuid K., Phadungcharoen T., Krungkrai J. 1998. Antimalarial xanthones from Garcinia cowa. Planta Medica, 64, 70–72. DOI: 10.1055/s-2006-957370CrossRefGoogle Scholar
  18. Lim P., Alker A.P., Khim N., Shah N.K., Incardona S., Doung S., Yi P., Bouth D.M., Bouchier C., Puijalon O.M., Meshnick S.R., Wongsrichanalai C., Fandeur T., Le Bras J., Ringwald P., Ariey F. 2009. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malaria Journal, 8, 11. DOI: 1475-2875-8-11 [pii]10.1186/1475-2875-8-11CrossRefGoogle Scholar
  19. Mahabusarakam W., Kuaha K., Wilairat P., Taylor W.C. 2006. Prenylated xanthones as potential antiplasmodial substances. Planta Medica, 72, 912–916. DOI: 10.1055/s-2006-947190CrossRefGoogle Scholar
  20. Meshnick S.R. 2002. Artemisinin: mechanisms of action, resistance and toxicity. International Journal for Parasitology, 32, 1655–1660. DOI: S0020751902001947 [pii]CrossRefGoogle Scholar
  21. Moongkarndi P., Kosem N., Kaslungka S., Luanratana O., Pongpan N., Neungton N. 2004. Antiproliferation, antioxidation and induction of apoptosis by Garcinia mangostana (mangosteen) on SKBR3 human breast cancer cell line. Journal of Ethnopharmacology, 90, 161–166. DOI: S0378874103003660 [pii]CrossRefGoogle Scholar
  22. Na-Bangchang K., Ruengweerayut R., Mahamad P., Ruengweerayut K., Chaijaroenkul W. 2010. Declining in efficacy of a threeday combination regimen of mefloquine-artesunate in a multidrug resistance area along the Thai-Myanmar border. Malaiar Journal, 9, DOI: 273.1475-2875-9-273[pii]10.1186/1475-9-2875-273Google Scholar
  23. Nabandith V., Suzui M., Morioka T., Kaneshiro T., Kinjo T., Matsumoto K., Akao Y., Iinuma M., Yoshimi N. 2004. Inhibitory effects of crude alpha-mangostin, a xanthone derivative, on two different categories of colon preneoplastic lesions induced by 1, 2-dimethylhydrazine in the rat. Asian Pacific Organization for Cancer Prevention, 5, 433–438Google Scholar
  24. Nguyen L.H., Venkatraman G., Sim K.Y., Harrison L.J. 2005. Xanthones and benzophenones from Garcinia griffithii and Garcinia mangostana. Phytochemistry, 66, 1718–1723CrossRefGoogle Scholar
  25. Noedl H., Se Y., Schaecher K., Smith B.L., Socheat D., Fukuda M.M. 2008. Evidence of artemisinin-resistant malaria in western Cambodia. The New England Journal of Medicine, 359, 2619–2620. DOI: NEJMc0805011 [pii]10.1056/NEJMc0805011CrossRefGoogle Scholar
  26. Obolskiy D., Pischel I., Siriwatanametanon N., Heinrich M. 2009. Garcinia mangostana L.: a phytochemical and pharmacological review. Phytotherapy Research 23, 1047–1065. DOI: 10.1002/ptr.2730CrossRefGoogle Scholar
  27. Pedraza-Chaverri J., Cardenas-Rodriguez N., Orozco-Ibarra M., Perez-Rojas J.M. 2008. Medicinal properties of mangosteen (Garcinia mangostana). Food and Chemical Toxicology, 46, 3227–3239. DOI: S0278-6915(08)00419-5 [pii]10.1016/j.fct.2008.07.024CrossRefGoogle Scholar
  28. Rogers W.O., Sem R., Tero T., Chim P., Lim P., Muth S., Socheat D., Ariey F., Wongsrichanalai C. 2009. Failure of artesunatemefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malaria Journal, 8, 10. DOI: 1475-2875-8-10 [pii]10.1186/1475-2875-8-10CrossRefGoogle Scholar
  29. Sakagami Y., Iinuma M., Piyasena K.G., Dharmaratne H.R. 2005. Antibacterial activity of alpha-mangostin against vancomycin resistant Enterococci (VRE) and synergism with antibiotics. Phytomedicine, 12, 203–208CrossRefGoogle Scholar
  30. Shan T., Ma Q., Guo K., Liu J., Li W., Wang F., Wu E. 2011. Xanthones from mangosteen extracts as natural chemopreventive agents: potential anticancer drugs. Current Molecular Medicine, 11, 666–677. DOI: BSP/CMM/E- Pub/00132 [pii]CrossRefGoogle Scholar
  31. Smilkstein M., Sriwilaijaroen N., Kelly J.X., Wilairat P., Riscoe M. 2004. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrobial Agents and Chemotherapy, 48, 1803–1806CrossRefGoogle Scholar
  32. Suksamrarn S., Komutiban O., Ratananukul P., Chimnoi N., Lartpornmatulee N., Suksamrarn A. 2006. Cytotoxic prenylated xanthones from the young fruit of Garcinia mangostana. Chemical and Pharmaceutical Bulletin (Tokyo), 54, 301–305. DOI: JST.JSTAGE/cpb/54.301 [pii]CrossRefGoogle Scholar
  33. Thiengsusuk A., Chaijaroenkul W., Na-Bangchang K., (2013). Antimalarial activities of medicinal plants and herbal formulations used in Thai traditional medicine. Parasitol Res, 112, 1475–1481. DOI: 10.1007/s00436-013-3294-6CrossRefGoogle Scholar
  34. Tona L., Cimanga R.K., Mesia K., Musuamba C.T., De Bruyne T., Apers S., Hernans N., Van Miert S., Pieters L., Totte J., Vlietinck A.J. 2004. In vitro antiplasmodial activity of extracts and fractions from seven medicinal plants used in the Democratic Republic of Congo. Journal of Ethnopharmacology, 93, 27–32. DOI: 10.1016/j.jep.2004.02.022S0378874104000844 [pii]CrossRefGoogle Scholar
  35. Vijaykadga S., Rojanawatsirivej C., Cholpol S., Phoungmanee D., Nakavej A., Wongsrichanalai C. 2006. In vivo sensitivity monitoring of mefloquine monotherapy and artesunatemefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Tropical Medicine & International Health, 11, 211–219. DOI: TMI1557 [pii]10.1111/j.1365-3156.2005.01557.xCrossRefGoogle Scholar
  36. Wongsrichanalai C., Pickard A.L., Wernsdorfer W.H., Meshnick S.R. 2002. Epidemiology of drug-resistant malaria. The Lancet Infectious Diseases, 2, 209–218. DOI:S1473309902002396 [pii]CrossRefGoogle Scholar

Copyright information

© W. Stefański Institute of Parasitology, PAS 2015

Authors and Affiliations

  1. 1.Center of Excellence in Molecular Biology and Pharmacology of Malaria and Cholangiocarcinoma, Chulabhorn International College of MedicineThammasat UniversityPatumthaniThailand

Personalised recommendations